Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical phenytoin vs topical fluocinolone for cutaneous lichen planus
IRCT2017081231028N3Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of phenytoin and fluocinolone in Cutaneous Lichen Planus (CLP) (2 arms), sponsored by Shiraz University of Medical Sciences. Started Mar 2013; status: completed.
02
Drugs
phenytoinfluocinolone
03
Conditions
Cutaneous Lichen Planus (CLP)
Beyond the preview
Go deeper on IRCT2017081231028N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017081231028N3.